NCT05927857 2026-04-09Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .National Health Research Institutes, TaiwanPhase 1/2 Recruiting45 enrolled